277 results
DEFA14A
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
3 Jun 24
Additional proxy soliciting materials
4:03pm
those transactions were consummated.
4.In our operating strategy, we rely heavily upon the talent of our most important resource, our people … have significant professional opportunities elsewhere. They have come to, and remain at, Ligand because they are excited about the strategy
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
pleased to report another quarter of strong financial results and we are now actively executing on our investment strategy as evidenced by the recent
8-K
EX-99.1
vb5f8608d
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-99.1
wmxkx
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
S-3ASR
lwinyq s3vs09usse5
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
9se ulwo42vni
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
aldz3u9rgh5z23cq
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
jzpws oajefu9
21 Jun 22
Regulation FD Disclosure
6:19am
425
of6vfu6hub0max8p2vg2
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
3qvla86fdv5ixmdyvh
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
crsdww79h6ov
24 Mar 22
Business combination disclosure
9:09am